Skip to content

Research & Literature

Published: | Updated:

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature

Visualize citation networks across 70 referenced papers

Top Authors

Top Institutions

References

  1. 1

    Direct Invasion of the Optic Nerves, Chiasm, and Tracts by Cryptococcus neoformans in an Immunocompetent Host.

    Merkler AE, Gaines N, Baradaran H, et al.

    The Neurohospitalist 2015; (5(4)):217-22 doi:10.1177/1941874415569072.

    PMID: 26425249
  2. 2

    Shunting in cryptococcal meningitis.

    Cherian J, Atmar RL, Gopinath SP

    Journal of neurosurgery 2016; (125(1)):177-86 doi:10.3171/2015.4.JNS15255.

    PMID: 26517766
  3. 3

    Cryptococcosis.

    Maziarz EK, Perfect JR

    Infectious disease clinics of North America 2016; (30(1)):179-206.

    PMID: 26897067
  4. 4

    Post-infectious inflammatory response syndrome (PIIRS): Dissociation of T-cell-macrophage signaling in previously healthy individuals with cryptococcal fungal meningoencephalitis.

    Williamson PR

    Macrophage 2015; (2()).

    PMID: 27064474
  5. 5

    Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis.

    Tugume L, Morawski BM, Abassi M, et al.

    HIV medicine 2017; (18(1)):13-20 doi:10.1111/hiv.12387.

    PMID: 27126930
  6. 6

    [Treatment of cryptococcal meningitis by use of shunting and review in literature].

    Zhao J, Liu J, Zhang Z, et al.

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2016; (41(5)):541-7 doi:10.11817/j.issn.1672-7347.2016.05.015.

    PMID: 27269931
  7. 7

    Repeated therapeutic lumbar punctures in cryptococcal meningitis - necessity and/or opportunity?

    Chang CC, Perfect JR

    Current opinion in infectious diseases 2016; (29(6)):539-545 doi:10.1097/QCO.0000000000000315.

    PMID: 27607912
  8. 8

    Integrated therapy for HIV and cryptococcosis.

    Srichatrapimuk S, Sungkanuparph S

    AIDS research and therapy 2016; (13(1)):42 doi:10.1186/s12981-016-0126-7.

    PMID: 27906037
  9. 9

    18F-FDG PET/CT and contrast-enhanced CT findings of pulmonary cryptococcosis.

    Wang SY, Chen G, Luo DL, et al.

    European journal of radiology 2017; (89()):140-148 doi:10.1016/j.ejrad.2017.02.008.

    PMID: 28267531
  10. 10

    Successful Treatment of Cryptococcal Meningitis with Amphotericin B in a Patient with Systemic Lupus Erythematosus.

    Jiang S, Lei TC, Xu SZ

    The West Indian medical journal 2015; (65(1)):222-225.

    PMID: 28319250
  11. 11

    Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis.

    Lofgren S, Hullsiek KH, Morawski BM, et al.

    The Journal of infectious diseases 2017; (215(5)):693-697 doi:10.1093/infdis/jix033.

    PMID: 28329080
  12. 12

    Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis.

    Mehta GU, Panackal AA, Murayi R, et al.

    Journal of neurology, neurosurgery, and psychiatry 2018; (89(2)):219-220 doi:10.1136/jnnp-2017-315830.

    PMID: 28550070
  13. 13

    Cross-Reacting Ustilago maydis Causing False-Positive Cryptococcal Antigen Test Results.

    Cheng MP, Nguyen TT, Parkes LO, et al.

    Journal of clinical microbiology 2017; (55(10)):3135-3137 doi:10.1128/JCM.00920-17.

    PMID: 28747366
  14. 14

    Cryptococcosis today: It is not all about HIV infection.

    O'Halloran JA, Powderly WG, Spec A

    Current clinical microbiology reports 2017; (4(2)):88-95 doi:10.1007/s40588-017-0064-8.

    PMID: 29130027
  15. 15

    Cryptococcus-Epithelial Interactions.

    Taylor-Smith LM

    Journal of fungi (Basel, Switzerland) 2017; (3(4)) doi:10.3390/jof3040053.

    PMID: 29371569
  16. 16

    Cryptococcal meningitis in AIDS.

    Spec A, Powderly WG

    Handbook of clinical neurology 2018; (152()):139-150 doi:10.1016/B978-0-444-63849-6.00011-6.

    PMID: 29604972
  17. 17

    Cryptococcal meningitis in a previously healthy child.

    Chimowa T, King I, Iroh Tam PY, Gonzalez-Martinez C

    Malawi medical journal : the journal of Medical Association of Malawi 2017; (29(4)):330-331 doi:10.4314/mmj.v29i4.10.

    PMID: 29963290
  18. 18

    Vision Loss in an 8-Year-Old Immunocompetent Boy with Cryptococcal Meningitis.

    Padmanabha H, Kasinathan A, Kumar A, et al.

    The Pediatric infectious disease journal 2018; (37(8)):e230-e232 doi:10.1097/INF.0000000000001911.

    PMID: 30004394
  19. 19

    Cryptococcal Meningitis: A Retrospective Cohort of a Brazilian Reference Hospital in the Post-HAART Era of Universal Access.

    de Azambuja AZ, Wissmann Neto G, Watte G, et al.

    The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2018; (2018()):6512468 doi:10.1155/2018/6512468.

    PMID: 30154942
  20. 20

    Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing.

    Rajasingham R, Wake RM, Beyene T, et al.

    Journal of clinical microbiology 2019; (57(1)) doi:10.1128/JCM.01238-18.

    PMID: 30257903
  21. 21

    HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts.

    Tugume L, Rhein J, Hullsiek KH, et al.

    The Journal of infectious diseases 2019; (219(6)):877-883 doi:10.1093/infdis/jiy602.

    PMID: 30325463
  22. 22

    Mycobacterium avium Complex Infection-Related Immune Reconstitution Inflammatory Syndrome Mimicking Lymphoma in an Human Immunodeficiency Virus-Infected Patient.

    Sohn S, Shi HJ, Wang SH, et al.

    Infection & chemotherapy 2018; (50(4)):350-356 doi:10.3947/ic.2018.50.4.350.

    PMID: 30600659
  23. 23

    CRYPTOCOCCAL meningitis in a HIV negative newly diagnosed diabetic patient: a CASE report.

    Owuor OH, Chege P

    BMC infectious diseases 2019; (19(1)):5 doi:10.1186/s12879-018-3625-4.

    PMID: 30606110
  24. 24

    Cryptococcosis in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

    Baddley JW, Forrest GN,

    Clinical transplantation 2019; (33(9)):e13543 doi:10.1111/ctr.13543.

    PMID: 30900315
  25. 25

    Cryptococcal Meningitis in an Apparent Immunocompetent Patient.

    Poley M, Koubek R, Walsh L, McGillen B

    Journal of investigative medicine high impact case reports 2019; (7()):2324709619834578 doi:10.1177/2324709619834578.

    PMID: 30947544
  26. 26

    Disseminated cryptococcal infection in a patient with treatment-naïve chronic lymphocytic leukemia (CLL).

    Suleman A, Padmore R, Faught C, Cowan J

    IDCases 2019; (17()):e00566 doi:10.1016/j.idcr.2019.e00566.

    PMID: 31194156
  27. 27

    Factors Associated With Ventriculoperitoneal Shunt Placement in Patients With Cryptococcal Meningitis.

    Baddley JW, Thompson GR, Riley KO, et al.

    Open forum infectious diseases 2019; (6(6)):ofz241 doi:10.1093/ofid/ofz241.

    PMID: 31214629
  28. 28

    Pulmonary cryptococcosis characteristics in immunocompetent patients-A 20-year clinical retrospective analysis in China.

    Hou X, Kou L, Han X, et al.

    Mycoses 2019; (62(10)):937-944 doi:10.1111/myc.12966.

    PMID: 31287920
  29. 29

    Central Nervous System Cryptococcal Infections in Non-HIV Infected Patients.

    Beardsley J, Sorrell TC, Chen SC

    Journal of fungi (Basel, Switzerland) 2019; (5(3)) doi:10.3390/jof5030071.

    PMID: 31382367
  30. 30

    Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model.

    Chesdachai S, Rajasingham R, Nicol MR, et al.

    Open forum infectious diseases 2019; (6(10)) doi:10.1093/ofid/ofz369.

    PMID: 31420668
  31. 31

    Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and Outcomes.

    Pastick KA, Bangdiwala AS, Abassi M, et al.

    Open forum infectious diseases 2019; (6(11)):ofz478 doi:10.1093/ofid/ofz478.

    PMID: 32042847
  32. 32

    Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade.

    Naicker SD, Mpembe RS, Maphanga TG, et al.

    PLoS neglected tropical diseases 2020; (14(3)):e0008137 doi:10.1371/journal.pntd.0008137.

    PMID: 32231354
  33. 33

    HIV-Associated Histoplasmosis: Current Perspectives.

    Myint T, Leedy N, Villacorta Cari E, Wheat LJ

    HIV/AIDS (Auckland, N.Z.) 2020; (12()):113-125 doi:10.2147/HIV.S185631.

    PMID: 32256121
  34. 34

    Cryptococcal meningitis in an immunocompetent patient.

    Murphy LS, Lacy AJ, Smith AT, Shah KS

    The American journal of emergency medicine 2020; (38(11)):2492.e1-2492.e3 doi:10.1016/j.ajem.2020.05.115.

    PMID: 32534877
  35. 35

    A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.

    Alufandika M, Lawrence DS, Boyer-Chammard T, et al.

    AIDS (London, England) 2020; (34(9)):1425-1428 doi:10.1097/QAD.0000000000002556.

    PMID: 32590438
  36. 36

    A Rare Case of Cryptococcus gattii Meningitis in Advanced HIV Disease, Sagittal Thrombosis, and Immune Reconstitution Syndrome, Resolved With Isavuconazonium.

    Okudo J, Civelli VF, Narang VK, et al.

    Journal of investigative medicine high impact case reports 2020; (8()):2324709620959880 doi:10.1177/2324709620959880.

    PMID: 32935587
  37. 37

    Case Report: Cryptococcal meningitis in Hodgkin's Lymphoma patient receiving brentuximab-vedotin therapy.

    Cunha Pereira T, Rb-Silva R, Félix Soares R, et al.

    F1000Research 2020; (9()):687 doi:10.12688/f1000research.24816.2.

    PMID: 33024550
  38. 38

    Clinical Aspects of Immune Damage in Cryptococcosis.

    Anjum S, Williamson PR

    Current fungal infection reports 2019; (13(3)):99-108 doi:10.1007/s12281-019-00345-7.

    PMID: 33101578
  39. 39

    Cryptococcus neoformans-astrocyte interactions: effect on fungal blood brain barrier disruption, brain invasion, and meningitis progression.

    Woo YH, Martinez LR

    Critical reviews in microbiology 2021; (47(2)):206-223 doi:10.1080/1040841X.2020.1869178.

    PMID: 33476528
  40. 40

    Cryptococcal Immune Reconstitution Inflammatory Syndrome: From Blood and Cerebrospinal Fluid Biomarkers to Treatment Approaches.

    Brienze VMS, André JC, Liso E, Louis IV

    Life (Basel, Switzerland) 2021; (11(2)) doi:10.3390/life11020095.

    PMID: 33514007
  41. 41

    First report of cryptococcosis due to Cryptococcus gattii sensu stricto VGI in an Ivorian HIV negative patient.

    Bellet V, Kassi FK, Krasteva D, et al.

    Journal de mycologie medicale 2021; (31(2)):101113 doi:10.1016/j.mycmed.2021.101113.

    PMID: 33540367
  42. 42

    The granuloma in cryptococcal disease.

    Ristow LC, Davis JM

    PLoS pathogens 2021; (17(3)):e1009342 doi:10.1371/journal.ppat.1009342.

    PMID: 33735307
  43. 43

    Cryptococcus neoformans-Infected Macrophages Release Proinflammatory Extracellular Vesicles: Insight into Their Components by Multi-omics.

    Zhang L, Zhang K, Li H, et al.

    mBio 2021; (12(2)) doi:10.1128/mBio.00279-21.

    PMID: 33785616
  44. 44

    Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis.

    Molloy SF, Ross B, Kanyama C, et al.

    Open forum infectious diseases 2021; (8(4)):ofab066 doi:10.1093/ofid/ofab066.

    PMID: 33937434
  45. 45

    Cryptococcal meningitis presenting with acute hearing loss.

    Ali AA, Maaliki N, Oye M, Isache CL

    BMJ case reports 2021; (14(5)) doi:10.1136/bcr-2021-242059.

    PMID: 33947677
  46. 46

    Cryptococcus gattii meningitis complicated by immune reconstitution inflammatory syndrome in an apparent immunocompetent host in Malaysia.

    Chang CY, Mohd Shah SH, Lio JY, et al.

    Medical mycology case reports 2022; (35()):1-4 doi:10.1016/j.mmcr.2021.12.004.

    PMID: 34984166
  47. 47

    Recent Advances in Cryptococcus and Cryptococcosis.

    Firacative C, Trilles L, Meyer W

    Microorganisms 2021; (10(1)) doi:10.3390/microorganisms10010013.

    PMID: 35056462
  48. 48

    Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.

    Jarvis JN, Lawrence DS, Meya DB, et al.

    The New England journal of medicine 2022; (386(12)):1109-1120 doi:10.1056/NEJMoa2111904.

    PMID: 35320642
  49. 49

    Toward Simpler, Safer Treatment of Cryptococcal Meningitis.

    Moosa MS, Lessells RJ

    The New England journal of medicine 2022; (386(12)):1179-1181 doi:10.1056/NEJMe2201150.

    PMID: 35320648
  50. 50

    A case report of a brain herniation secondary to cryptococcal meningitis with elevated intracranial pressure in a patient with Human Immunodeficiency Virus/Acquired immunodeficiency syndrome (HIV/AIDS).

    Guevara N, Akande A, Chang MF, et al.

    IDCases 2022; (29()):e01554 doi:10.1016/j.idcr.2022.e01554.

    PMID: 35845828
  51. 51

    Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in Uganda.

    Levin AE, Bangdiwala AS, Nalintya E, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023; (76(3)):e759-e765 doi:10.1093/cid/ciac599.

    PMID: 35859045
  52. 52

    Access to Medicines for Treating People With Cryptococcal Meningitis.

    Burry J, Casas CP, Ford N

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023; (76(3)):e773-e775 doi:10.1093/cid/ciac689.

    PMID: 36037037
  53. 53

    Cryptococcal meningitis in people living with human immunodeficiency virus in Nepal: Perspectives from resource limited setting.

    Sharma S, Acharya J, Rijal N, et al.

    Mycoses 2023; (66(1)):47-51 doi:10.1111/myc.13526.

    PMID: 36067003
  54. 54

    Therapeutic Lumbar Punctures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?

    Kagimu E, Engen N, Ssebambulidde K, et al.

    Open forum infectious diseases 2022; (9(9)):ofac416 doi:10.1093/ofid/ofac416.

    PMID: 36092828
  55. 55

    Comparison of the clinical manifestations and chest CT findings of pulmonary cryptococcosis in immunocompetent and immunocompromised patients: a systematic review and meta-analysis.

    Xiong C, Lu J, Chen T, Xu R

    BMC pulmonary medicine 2022; (22(1)):415 doi:10.1186/s12890-022-02175-9.

    PMID: 36369001
  56. 56

    Clinical characteristics and prognostic factors of 60 patients with acquired immune deficiency syndrome combined with Cryptococcus neoformans.

    Liu S, Chen W, Cheng F, et al.

    BMC infectious diseases 2023; (23(1)):204 doi:10.1186/s12879-023-08137-8.

    PMID: 37024795
  57. 57

    Diagnostic performance of the IMMY cryptococcal antigen lateral flow assay on serum and cerebrospinal fluid for diagnosis of cryptococcosis in HIV-negative patients: a systematic review.

    Macrae C, Ellis J, Keddie SH, et al.

    BMC infectious diseases 2023; (23(1)):209 doi:10.1186/s12879-023-08135-w.

    PMID: 37024842
  58. 58

    Cryptococcal Meningitis in Young, Immunocompetent Patients: A Single-Center Retrospective Case Series and Review of the Literature.

    Stack M, Hiles J, Valinetz E, et al.

    Open forum infectious diseases 2023; (10(8)):ofad420 doi:10.1093/ofid/ofad420.

    PMID: 37636518
  59. 59

    Diagnosis and management of cryptococcal meningitis in HIV-infected adults.

    McHale TC, Boulware DR, Kasibante J, et al.

    Clinical microbiology reviews 2023; (36(4)):e0015622 doi:10.1128/cmr.00156-22.

    PMID: 38014977
  60. 60

    Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM.

    Chang CC, Harrison TS, Bicanic TA, et al.

    The Lancet. Infectious diseases 2024; (24(8)):e495-e512 doi:10.1016/S1473-3099(23)00731-4.

    PMID: 38346436
  61. 61

    Complex Decisions in HIV-Related Cryptococcosis: Addressing Second Episodes of Cryptococcal Meningitis.

    Musubire A, Kagimu E, Mugabi T, et al.

    Current HIV/AIDS reports 2024; (21(2)):75-85 doi:10.1007/s11904-024-00691-3.

    PMID: 38400871
  62. 62

    Comparison of Early Fungicidal Activity and Mortality Between Daily Liposomal Amphotericin B and Daily Amphotericin B Deoxycholate for Cryptococcal Meningitis.

    Kimuda S, Kwizera R, Dai B, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025; (80(1)):153-159 doi:10.1093/cid/ciae326.

    PMID: 38943665
  63. 63

    Evaluation of the diagnostic performance of a semi-quantitative lateral flow assay for the detection of Cryptococcus antigen in serum and cerebrospinal fluid specimens.

    Castañeda-Torres MC, Arango J, Zuluaga A, et al.

    Medical mycology 2024; (63(1)) doi:10.1093/mmy/myae116.

    PMID: 39657327
  64. 64

    Comparison of mNGS with conventional methods for diagnosis of cryptococcal meningitis: a retrospective study.

    Jiang ZJ, Hong JC, Lin BW, et al.

    Scientific reports 2025; (15(1)):3656 doi:10.1038/s41598-025-86481-2.

    PMID: 39880818
  65. 65

    Neurocognitive Impairment Among Cryptococcal Meningitis Survivors in Uganda, a Prospective Cohort Study.

    Nsangi L, Hullsiek KH, Dai B, et al.

    Open forum infectious diseases 2025; (12(2)):ofaf054 doi:10.1093/ofid/ofaf054.

    PMID: 40008306
  66. 66

    Superior diagnostic performance of Grocott methenamine silver staining in pulmonary cryptococcosis: a multicenter, large-sample cohort study.

    Wang S, Lai J, Zheng C, et al.

    Frontiers in microbiology 2025; (16()):1615057 doi:10.3389/fmicb.2025.1615057.

    PMID: 40535006
  67. 67

    The Pain Is in the Brain With the Sugar-Coated Killer.

    Messina JA, Perfect JR

    The Journal of infectious diseases 2025; (232(6)):1265-1272 doi:10.1093/infdis/jiaf496.

    PMID: 40991722
  68. 68

    Phasing out India ink: the case for the CrAg LFA in modern practice.

    Morjaria S, Iturralde D, Clarck B, Babady NE

    Microbiology spectrum 2026; (14(1)):e0153125 doi:10.1128/spectrum.01531-25.

    PMID: 41347782
  69. 69

    Cryptococcal Infection in a Patient With Chronic Lymphocytic Leukaemia Receiving Acalabrutinib, a Bruton's Tyrosine Kinase Inhibitor: A Case Report.

    Al-Shaker AN, Agarwal A, Saeed MT, Marney Z

    Cureus 2025; (17(12)):e99241 doi:10.7759/cureus.99241.

    PMID: 41404449
  70. 70

    Cryptococcal antigen titers and semi-quantitative assay scores among people with HIV-associated cryptococcal antigenemia.

    Mwamba TM, Blasich NP, Coetzee LM, et al.

    Journal of clinical microbiology 2026; (64(2)):e0088625 doi:10.1128/jcm.00886-25.

    PMID: 41537580